Pko Investment Management Joint Stock CO Gilead Sciences, Inc. Transaction History
Pko Investment Management Joint Stock CO
- $1.17 Trillion
- Q3 2025
A detailed history of Pko Investment Management Joint Stock CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 38,000 shares of GILD stock, worth $4.72 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
38,000
Previous 9,000
322.22%
Holding current value
$4.72 Million
Previous $998 Million
322.72%
% of portfolio
0.36%
Previous 0.11%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
2,367Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...